Organon & Co. (OGN) is a publicly traded Healthcare sector company. As of May 21, 2026, OGN trades at $13.40 with a market cap of $3.52B and a P/E ratio of 14.29. OGN moved +0.34% today. Year to date, OGN is +80.91%; over the trailing twelve months it is +53.65%. Its 52-week range spans $5.69 to $19.41. Analyst consensus is neutral with an average price target of $11.25. Rallies surfaces OGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded OGN stock?
Recent politician trading activity in OGN includes disclosures from Gary Peters, Gary Peters, and John W. Hickenlooper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
OGN Key Metrics
Key financial metrics for OGN
Metric
Value
Price
$13.40
Market Cap
$3.52B
P/E Ratio
14.29
EPS
$0.94
Dividend Yield
0.02%
52-Week High
$19.41
52-Week Low
$5.69
Volume
2
Avg Volume
0
Revenue (TTM)
$6.16B
Net Income
$246.00M
Gross Margin
52.81%
Congressional Trades in OGN
Gary Peters sale OGN on Oct 7, 2025 (amount: $15.00K) for Self.
Gary Peters sale (full) OGN on Jul 10, 2025 (amount: $15.00K) for Self.
John W. Hickenlooper sale (full) OGN on Jun 28, 2021 (amount: $15.00K) for Self.
Recent politician trading activity in OGN includes disclosures from Gary Peters, Gary Peters, and John W. Hickenlooper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in OGN?
Yes. Rallies tracks politician and congressional stock disclosures for OGN, including reported purchases, sales, dates, owners, and trade amounts when available.
Is OGN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OGN. It does not provide personalized investment advice.
